Concepedia

Dose adjustment in patients with liver cirrhosis: impact on adverse drug reactions and hospitalizations

Carmen C. Franz, Carole Hildbrand, Christa Born, Sabin S Egger, Alexandra E. Rätz Bravo, Stephan Krähenbühl

European Journal of Clinical Pharmacology · 2013 · 64 citations · 10 references

DOIFull text

Open access

Concepts

References

10

Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction

Roger K. Verbeeck · European Journal of Clinical Pharmacology · 2008 · 638 citations

, , +14

Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis

Tilman Bauer, Bernhard Steinbrückner, Folke Brinkmann et al. · The American Journal of Gastroenterology · 2001 · 262 citations

, , +12

Liver disease selectively modulates cytochrome P450–mediated metabolism

Reginald F. Frye, N ZGHEIB, Gary R. Matzke et al. · Clinical Pharmacology & Therapeutics · 2006 · 246 citations

, , +16

Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis.

A.J. MacGilchrist, G G Birnie, Abigail Cook et al. · Gut · 1986 · 177 citations · Full text

, , +17

Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective

Jasmohan S. Bajaj, Ashwin N. Ananthakrishnan, Muhammad Hafeezullah et al. · The American Journal of Gastroenterology · 2009 · 172 citations

, , +11